DSIP 5mg from Adaptog Peptides, also known as Delta Sleep-Inducing Peptide, is a nine-amino-acid research compound used in studies on sleep architecture, circadian rhythm, and stress-response modelling. Researchers value DSIP for its well-documented profile in slow-wave sleep investigations and its modulatory activity across several neuroendocrine pathways. Adaptog supplies DSIP 5mg as a high-purity reagent for controlled laboratory work.
DSIP holds a unique position in neuropeptide research because of its associations with delta-wave sleep activity, hormonal modulation, and stress-buffering pathways. Although its precise receptor target remains an active area of investigation, DSIP continues to feature in studies exploring sleep regulation, neuroprotection, and pituitary signalling. Adaptog Peptides supplies DSIP 5mg as a stable, high-purity reagent suited to such investigations.
Researchers often buy DSIP 5mg from Adaptog Peptides for projects such as:
Investigating slow-wave sleep patterns in controlled models
Examining DSIP’s modulatory role in cortisol and growth-hormone pathways
Studying circadian-related signalling and rhythm research
Exploring neuroprotective markers under stress conditions
Because DSIP intersects sleep biology, neuroendocrinology, and stress research, it supports a broad range of investigative work. Adaptog Peptides delivers DSIP 5mg as a laboratory reagent prepared exclusively for qualified research environments. It is not intended for clinical, diagnostic, or therapeutic application.
For research use only. Not for human consumption.
DSIP holds a unique position in neuropeptide research because of its associations with delta-wave sleep activity, hormonal modulation, and stress-buffering pathways. Although its precise receptor target remains an active area of investigation, DSIP continues to feature in studies exploring sleep regulation, neuroprotection, and pituitary signalling. Adaptog Peptides supplies DSIP 5mg as a stable, high-purity reagent suited to such investigations.
Researchers often buy DSIP 5mg from Adaptog Peptides for projects such as:
Investigating slow-wave sleep patterns in controlled models
Examining DSIP’s modulatory role in cortisol and growth-hormone pathways
Studying circadian-related signalling and rhythm research
Exploring neuroprotective markers under stress conditions
Because DSIP intersects sleep biology, neuroendocrinology, and stress research, it supports a broad range of investigative work. Adaptog Peptides delivers DSIP 5mg as a laboratory reagent prepared exclusively for qualified research environments. It is not intended for clinical, diagnostic, or therapeutic application.
For research use only. Not for human consumption.
| Type | Synthetic compound |
|---|---|
| Category | Research Compound |
| Purity | ≥99% |
| Form | Lyophilized powder |
-20°C · 24+ months
2–8°C · ~30 days
Third-party tested for purity and quality.
| Variant | GLP3-RT 10mg |
|---|---|
| Lot # | REF0001 |
| Labeled | 20mg |
| Actual | 22.61mg |
| Tested | APR 15, 2026 |
Triple–Hormone-Receptor Agonist GLP-3 (RT) for Obesity — A Phase 2 Trial
2023
DOI: 10.1056/NEJMoa2301972
· Jastreboff AM, et al.
Triple–Hormone-Receptor Agonist GLP-3 (RT) for Obesity — A Phase 2 Trial
2023
DOI: 10.1056/NEJMoa2301972
· Jastreboff AM, et al.
Triple–Hormone-Receptor Agonist GLP-3 (RT) for Obesity — A Phase 2 Trial
2023
DOI: 10.1056/NEJMoa2301972
· Jastreboff AM, et al.
Not a researcher? Exit
